CH587237A5 - - Google Patents

Info

Publication number
CH587237A5
CH587237A5 CH1647576A CH1647576A CH587237A5 CH 587237 A5 CH587237 A5 CH 587237A5 CH 1647576 A CH1647576 A CH 1647576A CH 1647576 A CH1647576 A CH 1647576A CH 587237 A5 CH587237 A5 CH 587237A5
Authority
CH
Switzerland
Application number
CH1647576A
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH587237A5 publication Critical patent/CH587237A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CH1647576A 1971-04-01 1972-03-30 CH587237A5 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2115926A DE2115926C3 (de) 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
CH482372A CH587236A5 (sv) 1971-04-01 1972-03-30

Publications (1)

Publication Number Publication Date
CH587237A5 true CH587237A5 (sv) 1977-04-29

Family

ID=5803592

Family Applications (6)

Application Number Title Priority Date Filing Date
CH1647576A CH587237A5 (sv) 1971-04-01 1972-03-30
CH1390275A CH572905A5 (en) 1971-04-01 1972-03-30 Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity
CH1390475A CH580069A5 (sv) 1971-04-01 1972-03-30
CH1056976A CH590219A5 (sv) 1971-04-01 1972-03-30
CH1390375A CH580068A5 (sv) 1971-04-01 1972-03-30
CH482372A CH587236A5 (sv) 1971-04-01 1972-03-30

Family Applications After (5)

Application Number Title Priority Date Filing Date
CH1390275A CH572905A5 (en) 1971-04-01 1972-03-30 Sulphamido-aralkylamine cpds - with vasodilatory, cardiac-stimulant, blood-pressure, and broncholytic activity
CH1390475A CH580069A5 (sv) 1971-04-01 1972-03-30
CH1056976A CH590219A5 (sv) 1971-04-01 1972-03-30
CH1390375A CH580068A5 (sv) 1971-04-01 1972-03-30
CH482372A CH587236A5 (sv) 1971-04-01 1972-03-30

Country Status (20)

Country Link
US (1) US4038314A (sv)
JP (3) JPS5735193B1 (sv)
AR (6) AR204905A1 (sv)
AT (7) AT327174B (sv)
AU (1) AU470838B2 (sv)
BE (1) BE781542A (sv)
CH (6) CH587237A5 (sv)
DE (1) DE2115926C3 (sv)
DK (1) DK140836B (sv)
ES (4) ES401332A1 (sv)
FI (1) FI58325C (sv)
FR (1) FR2132372B1 (sv)
GB (1) GB1381184A (sv)
IE (1) IE36240B1 (sv)
IL (1) IL39110A (sv)
NL (1) NL170850C (sv)
NO (1) NO135247C (sv)
PH (1) PH14121A (sv)
SE (1) SE393106B (sv)
ZA (1) ZA722177B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
DE3220598A1 (de) * 1982-06-01 1983-12-01 Boehringer Ingelheim KG, 6507 Ingelheim Lipolytische zusammensetzungen und mittel zur behandlung der fettsucht
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
PT88988B (pt) * 1987-11-13 1993-02-26 Glaxo Group Ltd Processo para a preparacao de derivados da fenetanolamina
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US20040127733A1 (en) 2002-10-31 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
DE102004021779A1 (de) 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7718822B2 (en) 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
CN109535007A (zh) * 2018-11-07 2019-03-29 万华化学集团股份有限公司 一种二氨基二环己基甲烷同分异构体分离方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3804834A (en) * 1967-10-16 1974-04-16 Boehringer Sohn Ingelheim 1-(2',3',4'-trisubstituted-phenyl)-2-amino-alkanols-(1)and salts thereof
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament

Also Published As

Publication number Publication date
CH580069A5 (sv) 1976-09-30
AT326628B (de) 1975-12-29
SE393106B (sv) 1977-05-02
CH590219A5 (sv) 1977-07-29
AU470838B2 (en) 1973-10-04
ZA722177B (en) 1973-12-19
AR210055A1 (es) 1977-06-30
FR2132372A1 (sv) 1972-11-17
NO135247C (sv) 1977-03-09
JPS5718662A (en) 1982-01-30
ES419935A1 (es) 1976-05-01
NO135247B (sv) 1976-11-29
ATA915074A (de) 1975-04-15
DK140836B (da) 1979-11-26
ES419934A1 (es) 1976-05-01
JPS5718660A (en) 1982-01-30
DE2115926A1 (de) 1972-10-12
ES401332A1 (es) 1975-02-16
FR2132372B1 (sv) 1975-06-20
AT321888B (de) 1975-04-25
FI58325C (fi) 1981-01-12
AR200116A1 (es) 1974-10-24
FI58325B (fi) 1980-09-30
IE36240B1 (en) 1976-09-15
IE36240L (en) 1972-10-01
JPS5735193B1 (sv) 1982-07-27
CH587236A5 (sv) 1977-04-29
DE2115926C3 (de) 1978-05-03
AU4059272A (en) 1973-10-04
ATA284472A (de) 1975-03-15
AT321889B (de) 1975-04-25
CH580068A5 (sv) 1976-09-30
NL170850C (nl) 1983-01-03
JPS5929191B2 (ja) 1984-07-18
US4038314A (en) 1977-07-26
NL7204316A (sv) 1972-10-03
AT320613B (de) 1975-02-25
CH572905A5 (en) 1976-02-27
ES419936A1 (es) 1976-05-01
AR200002A1 (es) 1974-10-15
IL39110A (en) 1975-02-10
AR199809A1 (es) 1974-09-30
AR209268A1 (es) 1977-04-15
IL39110A0 (en) 1972-05-30
GB1381184A (en) 1975-01-22
JPS5929190B2 (ja) 1984-07-18
NL170850B (nl) 1982-08-02
AT327173B (de) 1976-01-26
DE2115926B2 (de) 1977-09-15
DK140836C (sv) 1980-04-21
PH14121A (en) 1981-02-26
BE781542A (fr) 1972-10-02
AT327174B (de) 1976-01-26
ATA915174A (de) 1975-04-15
AR204905A1 (es) 1976-03-19

Similar Documents

Publication Publication Date Title
NO135247C (sv)
ATA136472A (sv)
AR196074A1 (sv)
AU2658571A (sv)
AU2564071A (sv)
AU3005371A (sv)
AU2894671A (sv)
AU2742671A (sv)
AU2485671A (sv)
AR202997Q (sv)
AU2726271A (sv)
AU2588771A (sv)
AU2486471A (sv)
AU2577671A (sv)
AU2875571A (sv)
AU2473671A (sv)
AU2456871A (sv)
AU2455871A (sv)
AU2415871A (sv)
AU2940971A (sv)
AU2399971A (sv)
AU1109576A (sv)
AU2938071A (sv)
AU2654071A (sv)
AR199640Q (sv)

Legal Events

Date Code Title Description
PL Patent ceased